|
|
|
Insider
Information: |
Apple Robert F |
Relationship: |
President and CEO, Dir... |
City: |
Blue Bell |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-58.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Antares Pharma Inc |
ATRS |
President and CEO, Dir... |
2022-05-24 |
0 |
2007-05-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATRS |
Antares Pharma Inc |
President & CEO |
|
2017-06-02 |
4 |
D |
$2.57 |
$97,747 |
D/D |
(38,034) |
837,522 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2017-06-07 |
4 |
A |
$2.66 |
$899,386 |
D/D |
338,115 |
1,175,637 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2017-12-27 |
4 |
OE |
$1.23 |
$73,800 |
D/D |
60,000 |
929,719 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2017-12-27 |
4 |
D |
$2.35 |
$93,335 |
D/D |
(39,717) |
890,002 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
113,835 |
1,289,472 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-02-22 |
4 |
D |
$2.20 |
$81,402 |
D/D |
(37,001) |
1,252,471 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-05-11 |
4 |
OE |
$0.85 |
$70,125 |
D/D |
82,500 |
1,334,971 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-05-11 |
4 |
D |
$2.52 |
$75,731 |
D/D |
(30,052) |
1,304,919 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-05-28 |
4 |
D |
$2.43 |
$32,756 |
D/D |
(13,480) |
1,291,439 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-06-02 |
4 |
D |
$2.69 |
$92,541 |
D/D |
(34,402) |
1,257,037 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-06-07 |
4 |
D |
$2.70 |
$86,484 |
D/D |
(32,031) |
1,225,006 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-06-08 |
4 |
A |
$2.70 |
$825,001 |
D/D |
305,556 |
1,530,562 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-08-21 |
4 |
OE |
$0.47 |
$20,210 |
D/D |
43,000 |
1,573,562 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2018-08-21 |
4 |
AS |
$3.75 |
$161,250 |
D/D |
(43,000) |
1,530,562 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
254,205 |
1,784,767 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-02-20 |
4 |
D |
$3.20 |
$231,184 |
D/D |
(72,245) |
1,712,522 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-06-02 |
4 |
D |
$2.79 |
$146,640 |
D/D |
(52,559) |
1,659,963 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-06-07 |
4 |
D |
$2.81 |
$137,510 |
D/D |
(48,936) |
1,611,027 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-06-08 |
4 |
D |
$2.81 |
$124,272 |
D/D |
(44,225) |
1,566,802 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-06-13 |
4 |
A |
$2.92 |
$824,999 |
D/D |
282,534 |
1,849,336 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-11-11 |
4 |
OE |
$1.10 |
$110,000 |
D/D |
100,000 |
1,949,336 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-11-11 |
4 |
D |
$3.77 |
$163,788 |
D/D |
(43,445) |
1,905,891 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-12-09 |
4 |
OE |
$1.52 |
$640,380 |
D/D |
308,000 |
1,906,891 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-12-09 |
4 |
S |
$4.58 |
$1,424,418 |
D/D |
(308,000) |
1,905,891 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
President & CEO |
|
2019-12-10 |
4 |
S |
$4.76 |
$278,358 |
D/D |
(58,524) |
1,905,891 |
0 |
- |
|
105 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|